Sep 2026· Small· pp.
e75478
· 0 citations· 286 references
Medicine
TL;DR
This review focuses on the fundamental photonic mechanisms of UCNPs, including rational dopant selection, core-shell structural engineering, and spectral tuning strategies, and advanced nanoplatforms that integrate UCNPs with stimuli-responsive carriers and targeting ligands, enabling site-specific activation, synergistic antibacterial functions, and multimodal therapeutic effects.
Abstract
The emergence of multidrug-resistant (MDR) bacteria necessitates the development of next-generation antimicrobial strategies beyond conventional antibiotics. Upconversion nanoparticles (UCNPs), owing to their anti-Stokes luminescence under near-infrared (NIR) excitation, offer a versatile platform for deep-tissue antibacterial photodynamic therapy (aPDT). This review focuses on the fundamental photonic mechanisms of UCNPs, including rational dopant selection, core-shell structural engineering, and spectral tuning strategies. These photophysical features are closely related to energy transfer pathways to PS-such as Förster resonance energy transfer (FRET), direct excitation, and under specific interfacial conditions, Dexter exchange-to optimize reactive oxygen species (ROS) generation efficiency. We also highlight advanced nanoplatforms that integrate UCNPs with stimuli-responsive carriers and targeting ligands, enabling site-specific activation, synergistic antibacterial functions, and multimodal therapeutic effects. Translational prospects and unresolved challenges are further discussed, with an emphasis on mechanistic insights and design principles toward clinically relevant UCNPs-enabled aPDT systems.
Cancer remains a significant threat to human health, and photodynamic therapy (PDT) is recognized as a clinically effective therapeutic strategy for tumor treatment owing to its high spatiotemporal control and minimal invasiveness. However, its application is constrained by critical limitations of conventional photosen...
Chen-Kun Gao, Bing-Rui Li, Hang Shangguan et al.· Nanoscale· 0 citations
This review examines COF-based aPDT from a structure-photophysics-ROS-biological response perspective and discusses the structural identity of COF-based platforms, core photodynamic mechanisms, photoactive building blocks, and enhancement strategies including metal coupling, targeting engineering, responsive release, p...
Ming-Can Zhao, Yuan-Dong Xie, Zhen-Yu Ma et al.· Wiley Interdisciplinary Revi...· 0 citations
A topology-driven excited-state engineering strategy for constructing conjugated oligomers with tailored excited-state manifolds and multi-channel excitation dynamics is reported, establishing conjugated oligomers as versatile candidates for NIR-II phototheranostics and cancer immunotherapy.
Yu-Liang Yang, Yi-Jian Gao, Ning Li et al.· Angewandte Chemie· 0 citations
Metallic nanostructures are versatile platforms for Nanomedicine due to their optical and catalytic properties. Their strong light absorption and efficient photothermal conversion have enabled photothermal therapy (PTT) to ablate tumors within the biologically transparent near-infrared windows. Recent advances in plasm...
Jose I. Garcia-Peiro, Fatima Escudero-Amate, J. L. Hueso· Nanoscale· 0 citations
Light-activated nanotherapeutics that generate reactive oxygen species (ROS) offer a resistance-independent antibacterial strategy. However, integrating transition metals with inorganic quantum dots (QDs) to modulate light-matter interactions and extend photoactivity into the near-infrared (NIR) windows remains largely...
S. U. Khan, Omer Faruk Ozelci, T. S. Kaya et al.· Small· 0 citations
Conventional chemotherapy with drug-loaded hybrid nanosystems is restricted by limited drug delivery, poor loading content, internal accumulation, or premature drug release. Drug-derived nanoreactors acting as self-therapeutic agents are considered a promising approach to address these challenges. Herein, we report a...
Antara Ghosh, Gourav Chakraborty, Subhabrata Guha et al.· Langmuir· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.